News » FDA

We at Caputron offer a wide variety of stimulation treatment devices for the mind as well as a number of compatible, high-quality accessories. But do you know about all forms of treatment available? One of them, transcranial magnetic stimulation (TMS), is sometimes confused with others including CES and tDCS, but it offers a completely different experience to the user. Today, let’s aid you in...

Cranial electrotherapy stimulation (CES) is one of the most respected and trusted current-based treatment solutions. FDA-cleared for use in addressing depression, anxiety and insomnia, the technology has been adopted in many healthcare environments to provide a compelling new form of care. With that said, those three conditions have one thing in common: they are all common in those dealing with addictions. Using them as...

Cranial electrotherapy stimulation – otherwise known as CES – is a treatment cleared by the FDA for addressing insomnia in patients. Completely non-invasive and safe, it works to encourage the brain to react appropriately to the need for rest. The severity of insomnia can vary depending on how early or late it occurs in a typical sleep cycle. Today, let’s explore in further detail...

Update: December 20, 2019 The Food and Drug Administration (FDA) has reclassified CES devices intended for the treatment of anxiety and/or insomnia from Class III to Class II medical devices. CES devices intended for the treatment of depression will remain Class III and need to file a premarket approval application (PMA) to retain clearance for depression. This article has been updated to reflect those...

Update: December 20, 2019 The Food and Drug Administration (FDA) has reclassified CES devices intended for the treatment of anxiety and/or insomnia from Class III to Class II medical devices. CES devices intended for the treatment of depression will remain Class III and need to file a premarket approval application (PMA) to retain clearance for depression. This article has been updated to reflect those...